2020 Competition Healthcare Provider Prescription 
PM360
NOVEMBER 13, 2023
Let’s get to the point: It’s time for pharma marketers and their media agencies to look beyond the “usual suspects” for new ways and new media partners to reliably deliver educational and promotional messages to healthcare providers (HCPs) specifically when they are in an action mindset.
European Pharmaceutical Review
NOVEMBER 8, 2022
In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. The new law will also require drug manufacturers to pay rebates to Medicare if they increase drug prices faster than consumer inflation. Measuring and rating biosimilar access.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 24, 2023
In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.
Clarify Health
DECEMBER 21, 2021
The No Surprises Act and Transparency in Coverage Rule The past two years have been monumental for healthcare transparency and reporting regulations. The No Surprises Act (NSA), signed into law in December 2020, and the Transparency in Coverage Rule (TiC), published in October 2020, will have significant implications for health plans in 2022.
Healthcare Success
MAY 9, 2022
We know that today’s healthcare consumers want instant and accessible services. . The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . Prescription refills. Patient verification. Elderly care.
Pharmaceutical Technology
JANUARY 6, 2023
In 2020, the Federal Trade Commission issued a report regarding settlements reached between brand and generic manufacturers in FY 2017 and noted that “for the first time since [FY] 2004, no settlement agreement in [FY] 2017 contains a no-[authorized generic] AG commitment.”. These actions allegedly led to the extension of Novartis’ patents.
Healthcare Success
MAY 9, 2022
We know that today's healthcare consumers want instant and accessible services. . The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . consumers at the beginning of 2020, when the COVID-19 pandemic hit.
Expert insights. Personalized for you.
52 
Let's personalize your content